- Home
- ACV vs AMRN Comparison
ACV vs AMRN Comparison
Compare ACV & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACV
- AMRN
- Stock Information
- Founded
- ACV 2015
- AMRN 1989
- Country
- ACV United States
- AMRN Ireland
- Employees
- ACV N/A
- AMRN N/A
- Industry
- ACV Finance/Investors Services
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- ACV Finance
- AMRN Health Care
- Exchange
- ACV Nasdaq
- AMRN Nasdaq
- Market Cap
- ACV 229.2M
- AMRN 216.0M
- IPO Year
- ACV N/A
- AMRN 1993
- Fundamental
- Price
- ACV $22.72
- AMRN $15.39
- Analyst Decision
- ACV
- AMRN Strong Sell
- Analyst Count
- ACV 0
- AMRN 1
- Target Price
- ACV N/A
- AMRN $12.00
- AVG Volume (30 Days)
- ACV 38.8K
- AMRN 97.6K
- Earning Date
- ACV 01-01-0001
- AMRN 07-30-2025
- Dividend Yield
- ACV 9.20%
- AMRN N/A
- EPS Growth
- ACV N/A
- AMRN N/A
- EPS
- ACV N/A
- AMRN N/A
- Revenue
- ACV N/A
- AMRN $214,112,000.00
- Revenue This Year
- ACV N/A
- AMRN N/A
- Revenue Next Year
- ACV N/A
- AMRN N/A
- P/E Ratio
- ACV N/A
- AMRN N/A
- Revenue Growth
- ACV N/A
- AMRN N/A
- 52 Week Low
- ACV $16.82
- AMRN $7.08
- 52 Week High
- ACV $23.74
- AMRN $17.49
- Technical
- Relative Strength Index (RSI)
- ACV 59.52
- AMRN 51.11
- Support Level
- ACV $22.32
- AMRN $15.11
- Resistance Level
- ACV $22.84
- AMRN $15.68
- Average True Range (ATR)
- ACV 0.23
- AMRN 0.54
- MACD
- ACV -0.03
- AMRN -0.29
- Stochastic Oscillator
- ACV 68.53
- AMRN 11.55
About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest
Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, limited-term, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It invests in a diversified portfolio of convertible securities, income-producing equity securities, and income-producing debt and other instruments of varying maturities, of which a majority of the managed assets are invested in convertibles.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.